Latest Headlines

Latest Headlines

Role of adaptor protein could point the way for new diabetes, cancer treatments

A protein known to be part of a complex communications network within the cell has also been found to be associated with important processes involved in cancer and diabetes.

Myriad and Gene By Gene resolve their differences over BRCA cancer Dx tests

Myriad Genetics and rival Gene By Gene put to rest their patent infringement fight over BRCA gene testing, though Myriad is continuing to battle other competitors over the same issue.

Exact will make its case on March 27 for FDA approval of a colon cancer Dx

Exact Sciences goes before an FDA panel of experts on March 27 to argue for approval of its new stool-based colorectal cancer diagnostic. But it may not be an easy sell.

NeoGenomics' 22 cancer tests hit the market

Florida's NeoGenomics has rolled out a number of new diagnostic tests that profile 22 different categories of cancer, including brain, lung, breast, cervix, colorectal, stomach, ovary, soft tissue, thyroid and various types of leukemia tumors.

MDxHealth teams up with Teva to distribute its prostate, brain cancer tests

Belgium's MDxHealth has partnered with generics maker Teva Pharmaceuticals to commercialize its ConfirmMDx for prostate cancer and PredictMDx for glioblastoma tests in Israel.

Epic Sciences teams with LabCorp to push its cancer diagnostic

San Diego's Epic Sciences is working to expand access to its novel cancer diagnostic, joining forces with global giant LabCorp to make the test available to European drug developers.

Discovery links genes to excess belly fat

New genes identified by scientists at the University of Louisville in Kentucky may indicate a person's predisposition to excess abdominal fat, which can be an indicator of more serious health conditions, such as cardiovascular disease, Type 2 diabetes and cancer.

Researchers from Singapore and China find a new esophageal cancer biomarker

Researchers in Singapore and China are putting into play a new biomarker that appears to help spot a common form of esophageal cancer. It also enables clinicians to identify patients with the disease facing dicey survival prospects.

Investigators find a way to keep stem cells' options open until they're needed

Knowing how to preserve human embryonic stem cells in their pluripotent state until they are needed will help scientists better harness these cells for use in a variety of therapies. Now researchers have identified a gene receptor and signaling pathway that plays an essential role in preserving hESCs in an undifferentiated state.

Ovarian cancer biomarker could predict treatment response and help prevent metastasis

A newly discovered biomarker may help identify patients who will respond best to treatment as well as present a target for new drugs to help prevent metastasis, according to research published in Nature Communications.